ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

NCPA: We’re on the Verge of Groundbreaking PBM Reforms

Alexandria, Va., Dec. 17, 2024 (GLOBE NEWSWIRE) -- The National Community Pharmacists Association (NCPA), which has lobbied for years for fairer prescription reimbursements and pharmacy benefit manager accountability, said today that community pharmacies are on the verge of groundbreaking and desperately needed PBM reform, as Congress readies a continuing resolution that includes two of the organization’s top priorities. 

“We’re very grateful that Congress has included NCPA’s top priorities in the continuing resolution, but now is not the time to celebrate, because the health insurance companies and their PBMs will try desperately to stop this measure from passing,” said NCPA CEO B. Douglas Hoey. “Independent pharmacists across the country have done the grassroots lobbying, the letter writing, the congressional visits, and all the news interviews. Their efforts and the NCPA team’s boots-on-the-ground lobbying have all put us in scoring position. Now we’re on the goal line, and we need to punch it into the end zone.”

Included in the CR is a provision that would require PBMs to reimburse pharmacies at NADAC plus the state’s fee for service dispensing fee for all Medicaid managed care programs in all 50 states. It would eliminate spread pricing and pay PBMs a flat administrative fee in all Medicaid managed care programs. The provision will save taxpayers approximately $1 billion over the next 10 years.

Another provision written into the CR would require the Centers for Medicare & Medicaid Services to establish reasonable and relevant contract terms, including pharmacy reimbursements, in Medicare Part D and create a mechanism for pharmacies to dispute contract violations and penalize PBMs. Medicare Part D prescriptions make up one-third of the average independent pharmacy’s business.

“The PBMs systematically reimburse pharmacies less than their cost to buy and dispense medicine. That guarantees huge financial losses and has led to thousands of pharmacy closures and a loss of access for patients,” said Hoey. “The provisions in this legislation will help ensure that pharmacies are reimbursed more fairly, and that their contracts with PBMs aren’t the completely one-sided, take-it-or-leave-it contracts currently offered by the PBMs and their big insurance plan owners.

“In the last two years, NCPA and our members and partners built a strong bipartisan majority in Congress in favor of these reforms, and we are grateful to all our champions on Capitol Hill for getting us to this point. Now it’s critical that Congress finishes the job and passes the continuing resolution.”

###

Founded in 1898, the National Community Pharmacists Association is the voice for the community pharmacist, representing over 18,900 pharmacies that employ more than 205,000 individuals nationwide. Community pharmacies are rooted in the communities where they are located and are among America’s most accessible health care providers. To learn more, visit www.ncpa.org.


Andie Pivarunas
National Community Pharmacists Association
703-600-1174
andrea.pivarunas@ncpa.org

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.